Cazenove Capital Management »

Celldex Therapeutics shares owned by Cazenove Capital Management

Quarter-by-quarter ownership of Celldex Therapeutics shares owned by Cazenove Capital Management from 13F filings

Historical chart of Cazenove Capital Management investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Cazenove Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Cazenove Capital Management

Quarter filed Position value Share count Share price at filing
2013-06-30 $624k 40k 15.61

More positions owned by Cazenove Capital Management

iShares Russell 1000 Value Index (IWD)
Avnet (AVT)
JPMorgan Chase & Co. (JPM)
iShares Dow Jones US Financial (IYF)
Micron Technology (MU)
SPDR DJ Global Titans (DGT)
Hollyfrontier Corp
Valero Energy Corporation (VLO)
SPDR Gold Trust (GLD)
Exxon Mobil Corporation (XOM)
Coca-Cola Company (KO)
Johnson & Johnson (JNJ)
Amazon (AMZN)
Spdr S&p 500 Etf (SPY)
Berkshire Hathaway (BRK.B)

View all positions for Cazenove Capital Management